STEMNESS CHARACTER OF HEDGEHOG (HH)-BMI1 PATHWAY PREDICTS UNFAVOURABLE CLINICAL OUTCOME IN OESOPHAGEAL CANCER PATIENTS UNDERGOING PREOPERATIVE CHEMORADIOTHERAPY

(1) KOBE ADVENTIST HOSPITAL, Division of Cancer, Chemotherapy, Kobe, Hyogo, Japan

(2) Department of Pathology, HyogoCollege of Medicine, Nishinomiya, Hyogo, Japan

(3) Department of Surgery, KinkiUniversity, Nara Hospital, Nara, Japan



This item was part of the Free Paper Session: Stem cells in cancer session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A23